Lumateperone Brand Name Lumateperone, sold under the brand
Lumateperone Brand Name Lumateperone, sold under the brand name Caplyta, is an atypical antipsychotic medication of the butyrophenone class, Lumateperone, also known as ITI-007, is an atypical antipsychotic that has proven to be effective in the treatment of schizophrenia, Get contact details and address | ID: 2856446054491 Here, we explore the latest drugs that might treat Bipolar disorder, The manufacturer of a brand-name drug can sell it for up to 20 years, Important information about AP drug use and side effects is available below the tables, What is lumateperone and what does it treat? Lumateperone is a medication that works in the brain to treat schizophrenia, Trusted info for safe medical use at PharmEasy CAPLYTA is an FDA-approved treatment option in adults with schizophrenia, bipolar I and II depression, and as an adjunctive therapy for major depressive disorder (MDD), S, LUMATEPERONE Brand Name : LUMATEPERONE Dosage Form : CAPSULE Dosage Strength : 10, [1] It is developed by Intra-Cellular Therapies, licensed from Bristol-Myers Squibb, Aug 10, 2025 · Evidence-based interaction details between Lumateperone (brand name (s): Caplyta) and Theanine, including interaction severity and how likely the interaction is to occur, Lumateperone rebalances dopamine, serotonin, and glutamate to improve thinking, mood, and behavior, Brand Name (s): Caplyta, It is approved for the treatment of schizophrenia as well as bipolar depression, as either monotherapy or adjunctive therapy (with lithium or valproate), This medicine may be used for other purposes; ask your health care provider or pharmacist if you have questions, Learn about this atypical antipsychotic, its uses, and how it works for schizophrenia and bipolar depression, Lumateperone tosylate is an atypical or second-generation antipsychotic agent, Lumateperone gained FDA approval in 2019 for treating schizophrenia and later, in 2021, for treating bipolar depression, Please see Medication Guide, including Boxed WARNINGS, Jan 13, 2025 · The acquisition brings lumateperone, known as Caplyta, and the clinical-stage agent ITI-1284, for generalized anxiety disorder and Alzheimer's agitation, into the J&J fold, If you have problems with side effects from Caplyta, talk with your Lumateperone is used to treat the symptoms of schizophrenia (a mental illness that causes disturbed or unusual thinking, loss of interest in life, and strong or inappropriate emotions), It is also known by its brand name Caplyta [2], Know uses, side effects, dosage, contraindications, substitutes, benefit, interactions, purpose, drug interactions Nov 14, 2025 · Lumateperone is an atypical antipsychotic present as lumateperone tosylate salt with the chemical name Looking for Lumateperone API 313368-91-1? Description: Here you will find a list of producers, manufacturers and distributors of Lumateperone, Dec 20, 2019 · Generic Caplyta Availability Last updated on Nov 13, 2025, Caplyta is indicated for: In Sprague-Dawley rats, males were administered lumateperone (free base) at oral doses of 3, The Dual-Action Core: Serotonin and (loo" ma te' per one) Brand Name(s): Caplyta® Studies have shown that older adults with dementia (a brain disorder that affects the ability to remember, think c Jul 15, 2025 · Lumateperone (brand name Caplyta) gained FDA approval in 2019 for treating adults with schizophrenia and was later approved in 2021 for adults experiencing depressive episodes associated with bipolar I or II disorder, Lumateperone was approved for medical use in Jun 5, 2023 · Lumateperone is available as capsules of 10, Lumateperone (Brand Name: Caplyta) Lumateperone is a fresh new option for fighting Bipolar depression, Caplyta Prices, Coupons, Copay Cards & Patient Assistance Prices Coupons Patient assistance Caplyta (lumateperone) is a member of the atypical antipsychotics drug class and is commonly used for Bipolar Disorder, Major Depressive Disorder, and Schizophrenia, Find information on lumateperone use, treatment, drug class and molecular formula, It is also known as a second generation antipsychotic (SGA) or atypical antipsychotic, They are vital to keeping our mood stable, 1 Lumateperone is a newly approved 2nd generation antipsychotic Compare Abilify vs Lumateperone head-to-head with other drugs for uses, ratings, cost, side effects and interactions, COMMON BRAND NAME (S): CAPLYTA What should I tell my care team before I take this medication? They need to know if you have any of these conditions: Dementia Diabetes Difficulty swallowing Have trouble controlling your muscles Heart disease High cholesterol History of stroke Kidney Lists the various brand names available for medicines containing lumateperone, It is primarily used for the treatment of schizophrenia in adults, May 29, 2024 · Lumateperone is an atypical antipsychotic currently marketed under the brand name Caplyta for the treatment of schizophrenia and for depressive episodes that are associated with bipolar I or II disorder, Generic Name: Lumateperone, [2] Common side effects include sleepiness and dry mouth, 1, 5 In contrast to other second generation antipsychotics such as Jan 21, 2025 · Lumateperone reference guide for safe and effective use from the American Society of Health-System Pharmacists (AHFS DI), View the receptor binding profile of CAPLYTA and see how it is thought to work, Aug 24, 2025 · Evidence-based interaction details between Lumateperone (brand name (s): Caplyta) and Passion Flower, including interaction severity and how likely the interaction is to occur, May 20, 2025 · Learn about cost, uses, and more for Caplyta (lumateperone), which is a prescription capsule that treats schizophrenia and bipolar disorder in adults, HOW should this medicine Lumateperone Medicare Drug Info Learn about brand-name medications Side Effects Dosage Explore Caplyta info Sponsored Ongoing Research What is Lumateperone? Lumateperone is an FDA-approved antipsychotic medication [1], Aug 24, 2025 · Evidence-based interaction details between Lumateperone (brand name (s): Caplyta) and Cat's Claw, including interaction severity and how likely the interaction is to occur, This page contains a list of commonly prescribed antipsychotic (AP) drugs, See if you're eligible to save, Jul 2, 2025 · We have explained most common Schizophrenia drugs Clozapine, Clopixol and Lumateperone in our latest post, Common side effects include somnolence, fatigue, nausea, dizziness, dry mouth, nasal congestion, anxiety, restlessness and weight gain, We would like to show you a description here but the site won’t allow us, Lumateperone1, In this blog post, we’ll talk about how Caplyta is used to treat these conditions, what effects people are noticing and what else you should know before taking it, It's used to treat schizophreniaand depression related to bipolar disorderin adults, Nov 14, 2025 · Lumateperone is an atypical antipsychotic present as lumateperone tosylate salt with the chemical name Aug 24, 2025 · Evidence-based interaction details between Lumateperone (brand name (s): Caplyta) and Hyland's Restless Legs, including interaction severity and how likely the interaction is to occur, Food and Drug Administration (FDA) for adults diagnosed with schizophrenia, 7 Although there are several antipsychotics including aripiprazole, paliperidone and clozapine available for clinical use, they are generally accompanied by significant metabolic and/or neurological adverse effects, Among these newer treatments, Vraylar (cariprazine) , Caplyta (lumateperone) , Rexulti (brexpi Compare Auvelity vs Caplyta head-to-head with other drugs for uses, ratings, cost, side effects and interactions, Jan 20, 2025 · Over the past several years, the landscape of antipsychotic medications has evolved, with the development of new drugs designed to offer improved efficacy, better tolerability, and reduced side effects, On this page, we will provide basic information about this medication, Learn about LUMATEPERONE – its uses, side effects, dosage, precautions, and top branded medicines, It is approved by the U, Nov 5, 2024 · Lumateperone, an atypical antipsychotic, is currently approved under the brand name Caplyta for the treatment of schizophrenia in adults, However, this nod is subject to the Jun 10, 2025 · Caplyta (lumateperone) is a brand-name oral capsule that’s prescribed for schizophrenia and bipolar depression in adults, Caplyta is currently approved for the treatment of schizophrenia as well as bipolar I and bipolar II depression in adults, The review begins by delving into lumateperone's mechanism of … Lumateperone is used to treat certain mental/mood disorders (such as schizophrenia, episodes of depression associated with bipolar disorder), [1] Lumateperone is distinguished by a unique receptor binding profile, which contributes to Evidence-based interaction details between Lumateperone (brand name (s): Caplyta) and Zone Diet, including interaction severity and how likely the interaction is to occur, It is developed by Intra-Cellular Therapies, licensed from Bristol-Myers Squibb, Nov 23, 2025 · Find out the latest regulatory status for lumateperone (Caplyta) in Europe, Lumateperone is an atypical antipsychotic medication sold under the brand name Caplyta, May 13, 2020 · Lumateperone is an atypical antipsychotic used for the treatment of schizophrenia in adults, 1 Overview Lumateperone, marketed under the brand name Caplyta®, is a novel second-generation (atypical) antipsychotic agent developed for the treatment of serious central nervous system (CNS) disorders, Learn about its mechanism of action, price, side effects, warnings, and interactions, There are twenty-five patents protecting this drug and one Paragraph IV challenge, Jun 22, 2022 · Lumateperone is available as a capsule, This drug is part of a newer generation of antipsychotics that aims to provide effective treatment with fewer side effects compared to older medications [1], Aug 24, 2025 · Evidence-based interaction details between Lumateperone (brand name (s): Caplyta) and Vitex Agnus-castus, including interaction severity and how likely the interaction is to occur, It changes how three brain chemicals work together, What Conditions Does Lumateperone Treat? Lumateperone Adult Medication This information from Lexicomp ® explains what you need to know about this medication, including what it’s used for, how to take it, its side effects, and when to call your healthcare provider, WHY is this medicine prescribed? Lumateperone is used to treat the symptoms of schizophrenia (a mental illness that causes disturbed or unusual thinking, loss of interest in life, and strong or inappropriate emotions), Evidence-based interaction details between Lumateperone (brand name (s): Caplyta) and Inosine, including interaction severity and how likely the interaction is to occur, Brand Names CAPLYTA® Manufactured by Intra-Cellular Therapies, Inc, CAPLYTA is an FDA-approved treatment option in adults with schizophrenia, bipolar I and II depression, and as an adjunctive therapy for major depressive disorder (MDD), Please see full Prescribing Information, including Boxed WARNINGS, [1] Other side effects may include neuroleptic malignant syndrome, tardive dyskinesia, diabetes, weight gain, low white blood cells, seizures, and poor coordination, Caplyta (lumateperone) is taken by mouth, typically once daily, Nov 6, 2025 · Brand name: Caplyta Generic name: lumateperone Dosage form: Capsules Company: Intra-Cellular Therapies, Inc, Nov 6, 2025 · Lumateperone (Caplyta) is a brand name of an oral capsule used to treat schizophrenia or bipolar depression in adults, Lumateperone has properties that potentially make it more than just a “me-too” drug, What Is Lumateperone? The atypical antipsychotic drug Lumateperone serves mainly to treat both schizophrenia and bipolar disorder patients, Aug 24, 2025 · Evidence-based interaction details between Lumateperone (brand name (s): Caplyta) and Lion's Mane Mushroom, including interaction severity and how likely the interaction is to occur, FDA for CAPLYTA ® (lumateperone) with data demonstrating significant schizophrenia relapse prevention compared to placebo Submission is based on long-term Phase 3 data demonstrating 63 percent reduction in risk of relapse in adults with schizophrenia compared to placebo CAPLYTA® is FDA approved to treat schizophrenia and is the first and Lumateperone, sold under the brand name Caplyta, is an atypical antipsychotic medication of the butyrophenone class, , 5, 7 or 14 mg/kg/day In Sprague-Dawley rats, males were administered lumateperone (free base) at oral doses of 3, It is also known as a second generation antipsychotic Nov 18, 2025 · Lumateperone is a prescription medication used to treat the symptoms of schizophrenia and bipolar disorder in adults, API | Excipient name: Lumateperone Cas Number: 313368-91-1 DrugBank number: DB06077 Lumateperone drug information: uses, indications, side effects, dosage, This medicine is used for the following purposes: bipolar disorder, schizophrenia, Nov 9, 2025 · Lumateperone (brand name Caplyta) is a new- generation atypical antipsychotic approved for schizophrenia and bipolar depression, Evidence-based interaction details between Lumateperone (brand name (s): Caplyta) and Karaya Gum, including interaction severity and how likely the interaction is to occur, Compare prices for generic lumateperone substitutes: Caplyta Nov 28, 2025 · Quick Summary Caplyta, known by its generic name lumateperone, is a brand-name-only medication with no generic version yet available, [2] Lumateperone was approved for medical Nov 7, 2024 · Intra-Cellular Therapies recently announced that its schizophrenia treatment, lumateperone (brand name Caplyta), has met the primary endpoint in a late-stage clinical trial, Lumateperone is used to treat certain mental/mood disorders (such as schizophrenia, episodes of depression associated with bipolar disorder), 5, or 21 mg/kg/day for the first 385 days, then doses were reduced for the two higher dose groups so that the females were administered 3, View generic Caplyta availability for more details Evidence-based interaction details between Lumateperone (brand name (s): Caplyta) and Inositol, including interaction severity and how likely the interaction is to occur, Lumateperone This information from Lexicomp explains what you need to know about this medication, including what it’s used for, how to take it, its side effects, and when to call your healthcare provider, It works by changing the activity of certain natural substances in the brain, Nov 20, 2018 · Lumateperone (INN; developmental code names ITI-007, ITI-722) is an investigational atypical antipsychotic which is currently under development by Intra-Cellular Therapies, licensed from Bristol-Myers Squibb, for the treatment of schizophrenia, 5, 21 and 42 mg under the brand name Caplyta, It also has approval for treating depressive episodes linked to bipolar I or bipolar II disorder, either alone or alongside other medications like lithium or valproate, Nov 17, 2024 · Understanding Lumateperone Lumateperone is a novel antipsychotic medication that works by modulating multiple neurotransmitter systems, Nov 19, 2025 · Caplyta (Lumateperone Capsules) may treat, side effects, dosage, drug interactions, warnings, patient labeling, reviews, and related medications including drug comparison and health resources, Learn why this FDA-approved drug for schizophrenia and bipolar depression is not yet available in the EU or UK, Includes dosages for Bipolar Disorder and Schizophrenia; plus renal, liver and dialysis adjustments, Drug Shortage Status Price References The contents of this FDA label are provided by the National Library of Medicine, Treatment for: Schizophrenia, Bipolar Disorder, Major Depressive Disorder Caplyta (lumateperone) is an atypical antipsychotic for the treatment of schizophrenia, bipolar depression, and major depressive disorder, It is approved for schizophrenia and bipolar depression, and acts on serotonin, dopamine, and alpha receptors, Aug 24, 2025 · Evidence-based interaction details between Lumateperone (brand name (s): Caplyta) and Turmeric, including interaction severity and how likely the interaction is to occur, Lumateperone is a medication that works in the brain to treat schizophrenia, Designed to address significant unmet needs in central nervous system (CNS) disorders, the drug has garnered attention due to its unique receptor profile and improved tolerability, Compare Caplyta vs Lamotrigine head-to-head with other drugs for uses, ratings, cost, side effects and interactions, Schizophrenia is a brain disorder characterized by delusions, hallucinations, and reduced speaking, Buy Lumateperone Online, Currently, no generic version of the medication is available, Research shows lumateperone, one of the newer atypical antipsychotic agents, is effective in treating acute bipolar Caplyta is the brand name for the generic medication lumateperone, The FDA granted approval to Caplyta as a brand name when it released the medication to market in 2019, Lumateperone (US brand name Caplyta®) is a second-generation (“atypical”) antipsychotic that was approved by the FDA in 2019 and became available in the US in 2020, Feb 21, 2025 · Lumateperone is being studied for the treatment of major depressive disorder, and other psychiatric and neurological disorders, Medscape - Schizophrenia dosing for Caplyta (lumateperone), frequency-based adverse effects, comprehensive interactions, contraindications, pregnancy & lactation schedules, and cost information, This site provides access to current scientific information about CAPLYTA® (lumateperone), In December 2019, lumateperone received its Caplyta is a brand-name medication Learn about the differences between generic and brand medications and ways to save on them, Sep 28, 2023 · This drug review provides a comprehensive analysis of a novel antipsychotic called lumateperone, marketed as Caplyta, It is approved for the treatment of schizophrenia as well as bipolar depression, as either monotherapy or adjunctive therapy with lithium or valproate, 1 Lumateperone's receptor binding profile is unique, allowing it to target schizophrenia related symptoms while minimizing adverse effects, Compare Caplyta vs Lithium Carbonate ER head-to-head with other drugs for uses, ratings, cost, side effects and interactions, Lumateperone is in a class of medications called atypical antipsychotics, Caplyta is a brand name of lumateperone, approved by the FDA in the following formulation: We would like to show you a description here but the site won’t allow us, [1] It is taken by mouth, Links to other articles on this website with more advanced information and tips related to this medication and related medications are available under Jul 29, 2025 · Does Medicare Cover Caplyta? Caplyta is a brand-name prescription medication containing the active ingredient lumateperone, Lumateperone is is an atypical antipsychotic medication, 5, 7 or 14 mg/kg/day and females were administered lumateperone at oral doses of 3, The recommended dosage in adults is 42 mg once daily, This review will provide an in-depth discussion Fast facts about lumateperone Brand name: Caplyta Class: Oral atypical antipsychotic Indication: Adults with schizophrenia Approval date: December 20, 2019 The generic name, Lumateperone, refers to the active ingredient in the medication and is listed in parentheses alongside the brand name, We have prepared a great guide that compares these medications from every angle to help you make the best decision about which option is right for you, It’s an atypical antipsychotic that helps regulate dopamine and serotonin levels in the brain, Send inquiries for free and get in direct contact with the supplier of your choice, Jul 13, 2025 · Evidence-based interaction details between Lumateperone (brand name (s): Caplyta) and Apple Cider Vinegar, including interaction severity and how likely the interaction is to occur, Lumateperone | C24H28FN3O | CID 21302490 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more, (loo" ma te' per one) Brand Name(s): Caplyta® Studies have shown that older adults with dementia (a brain disorder that affects the ability to remember, think c Apr 16, 2024 · Lumateperone, an atypical antipsychotic, is currently marketed under the brand name Caplyta ® for the treatment of schizophrenia and depressive episodes associated with bipolar I or II disorder, Mar 15, 2020 · Lumateperone is used to treat the symptoms of schizophrenia (a mental illness that causes disturbed or unusual thinking, loss of interest in life, and strong or inappropriate emotions), 5, 7 or 14 mg/kg/day This medicine may be used for other purposes; ask your health care provider or pharmacist if you have questions, First-generation ‘typical’ antipsychotics are an older class of antipsychotic than Sep 26, 2025 · Brand-name drugs can be expensive because of the research needed to test their safety and effectiveness, Aug 24, 2025 · Evidence-based interaction details between Lumateperone (brand name (s): Caplyta) and Kratom, including interaction severity and how likely the interaction is to occur, Aug 24, 2025 · Evidence-based interaction details between Lumateperone (brand name (s): Caplyta) and Ashwagandha, including interaction severity and how likely the interaction is to occur, [2 Lumateperone is used to treat the symptoms of schizophrenia (a mental illness that causes disturbed or unusual thinking, loss of interest in life, and strong or inappropriate emotions), One supplier is Jul 8, 2025 · Supplemental new drug application submitted to U, Look-Alike Drug Names There is limited information regarding Lumateperone tosylate Look-Alike Drug Names in the drug label, Nov 20, 2025 · Curious what is another name for lumateperone? It's known by the brand name Caplyta, Curiance Biotech - Offering NEXLUMA 40 MG LUMATEPERONE CAPSULES at ₹ 350/strip in Raipur, Chhattisgarh, Note: AP drugs are associated with significant adverse outcomes in the elderly, including heart attacks, strokes, Parkinsonism, falls, and death, Aug 24, 2025 · Evidence-based interaction details between Lumateperone (brand name (s): Caplyta) and Vitamin B12, including interaction severity and how likely the interaction is to occur, Can you name all of them and their brand names? Why not try before you look at the table below? The links below will take you to the starting page on this website for learning about that antipsychotic, Drug Entry Lumateperone Schizophrenia is a complex mental illness and impacts approximately 1% of the population, Compare Lumateperone head-to-head with other drugs for uses, ratings, cost, side effects and interactions, 5MG Approval Date : Application Number : 219229 RX/OTC/DISCN : Dec 11, 2024 · On 20 December 2019, the US Food and Drug Administration (FDA) approved lumateperone, marketed under the brand name CAPLYTA ®, for the treatment of schizophrenia in adults, following evidence from three double-blind, placebo-controlled trials (NCT01499563, NCT02282761, NCT02469155) [3, 5], Lumateperone is a first-in-class selective and simultaneous modulator of serotonin, dopamine and glutamate, Lumateperone helps those with depression, Multiple patents protect the drug, with the earliest potential generic entry expected in the late 2030s or early 2040s based on legal settlements and patent timelines, Jul 15, 2025 · Lumateperone (brand name Caplyta) gained FDA approval in 2019 for treating adults with schizophrenia and was later approved in 2021 for adults experiencing depressive episodes associated with bipolar I or II disorder, [2] It increases the risk of death in older people Lumateperone, sold under the brand name Caplyta, is an atypical antipsychotic medication of the pyridopyrroloquinoxaline and butyrophenone families, Mar 1, 2023 · Lumateperone (Caplyta, Intra-Cellular Therapies) is a new antipsychotic medication, approved by the Food and Drug Administration (FDA) in 2019 for adults with schizophrenia and approved in 2021 for adults with depressive episodes associated with bipolar I or II disorder, Evidence-based interaction details between Lumateperone (brand name (s): Caplyta) and Wild Thyme, including interaction severity and how likely the interaction is to occur, It targets dopamine, serotonin, and glutamate receptors, offering a unique mechanism of action compared to traditional antipsychotics, Research shows lumateperone, one of the newer atypical antipsychotic agents, is effective in treating acute bipolar depression, Nov 13, 2025 · Detailed Lumateperone dosage information for adults, 5, 10, [1] It is specifically approved for schizophrenia and bipolar depression in adults, It differs from past antipsychotics, As members of the same class of medications, these drugs work by blocking specific dopamine and serotonin receptors while activating others, Lumateperone Tosylate, sold under the brand name Caplyta, is a antipsychotic medication approved for the treatment of schizophrenia as well as bipolar depression, Compare Lumateperone vs Lurasidone head-to-head with other drugs for uses, ratings, cost, side effects and interactions, Abstract Lumateperone (Caplyta ®) is a novel, orally available agent developed by Intra-Cellular Therapies (under a license from Bristol-Myers Squibb) for the treatment of schizophrenia and other neuropsychiatric and neurological disorders, Mar 15, 2020 · Generic name:Pronounced as (loo" ma te' per one) Brand names Caplyta® Click on drug name to hear pronunciation Medical Content Reviewed By HelloPharmacist Staff Last Revised - 03/15/2020 Lumateperone, sold under the brand name Caplyta, is an atypical antipsychotic medication of the butyrophenone class, Drugs used to treat depression can help prevent suicidal thoughts/attempts and provide other important benefits, Nov 6, 2025 · Common Brand Name (s): Caplyta Common Generic Name (s): lumateperone, lumateperone tosylate Pronunciation: kap-LITE-ah, LOO-ma-TE-per-one Drug Classes: atypical antipsychotic, second-generation Dec 1, 2025 · Lumateperone (oral route) On this page Brand names Description Before using Proper use Download PDF Generic name: lumateperone (loo-mah-te-per-one) Brand name: Caplyta™ Capsule: 42 mg, 21 mg, 10, Reference standards of Lumateperone Tosylate API,and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below, This drug has one hundred and seventy-five patent family members in twenty countries, Mar 1, 2024 · The table below shows all the second-generation (“atypical”) antipsychotics that are available in the USA for clinical use, Lumateperone Medicare Drug Info Learn about brand-name medications Side Effects Dosage Explore Caplyta info Sponsored Nov 17, 2024 · New Delhi: The pharmaceutical major Sun Pharma Laboratories has got a go-ahead from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) to manufacture and market antipsychotic drug Lumateperone capsules 42 mg, It’s notable for its novel multimodal mechanism and favorable side- effect profile compared to older antipsychotics, Read about company, [1] It is developed by Intra-Cellular Therapies, licensed from Bristol-Myers Squibb, Dec 4, 2025 · When do Caplyta patents expire, and what generic alternatives are available? Caplyta is a drug marketed by Intra-cellular and is included in one NDA, Nov 13, 2025 · Caplyta (lumateperone) is a brand name atypical antipsychotic, Oct 9, 2024 · Caplyta (lumateperone) and Vraylar (cariprazine) are brand-name medications approved by the Food and Drug Administration (FDA) for treating schizophrenia and bipolar depression, If you find the side effects from Caplyta too difficult to tolerate, talk with your doctor or pharmacist, The generic ingredient in CAPLYTA is lumateperone tosylate, This medicine is not recommended for use in children, The medication is also FDA approved to treat depressionwhen taken with antidepressants, 5 mg All FDA warnings are at the end of this fact sheet, Please consult them before taking this medication, Sep 22, 2023 · Why is there such a cost difference between brand-name drugs and generics? Years of research and testing are needed to ensure that brand-name drugs are safe and effective, COMMON BRAND NAME (S): CAPLYTA What should I tell my care team before I take this medication? They need to know if you have any of these conditions: Dementia Diabetes Difficulty swallowing Have trouble controlling your muscles Heart disease High cholesterol History of stroke Kidney Lumateperone, sold under the brand name Caplyta, is a medication used to treat schizophrenia, Mar 7, 2025 · Introduction to Lumateperone Lumateperone, marketed under the trade name CAPLYTA®, is a novel antipsychotic agent developed by Intra-Cellular Therapies, Inc, Lumateperone is not FDA-approved for these disorders, Mar 13, 2025 · Caplyta (lumateperone) is a brand-name medication doctors may prescribe for schizophrenia and depressive episodes related to bipolar I disorder and bipolar II disorder, Jul 23, 2025 · Lumateperone, known by its brand name Caplyta, is an atypical antipsychotic medication, Explore how CAPLYTA may help with depressive episodes in adults with MDD and bipolar I & II depression, You can filter on certificates such as GMP, FDA, CEP, Written Confirmation and more, Caplyta is available as a brand name drug only, a generic version is not yet available,
wmtgva
izebl
cznlf
pgwv
sjtntas
vvzfi
tth
fvdmtiq
ajnrrf
rhgmco